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Abstract
Age-related Macular Degeneration (AMD) is the leading cause of irreversible and predictable 
blindness among older adults and creates serious physical and mental health consequences for this 
population. Visual impairment is associated with negative future outlook and depression and has 
serious consequences for older adults’ quality of life and, by way of depression, on long-term 
survival. Psychosocial interventions have the potential to alleviate and prevent depression 
symptoms among older AMD patients. We describe the protocol of the Macular Degeneration and 
Aging Study, a randomized clinical trial of a psychosocial Preventive Problem-Solving 
Intervention. The intervention is aimed at enhancing well-being and future planning among older 
adults with macular degeneration by increasing preparation for future care. Adequate 
randomization and therapeutic fidelity were achieved. Current retention rates were acceptable, 
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given the vulnerability of the population. Acceptability (adherence and satisfaction) is high. Given 
the high public health significance and impact on quality of life among older adults with vision 
loss, this protocol contributes a valid test of a promising intervention for maintaining mental and 
physical health in this population.
Keywords
Randomized Controlled Trial; Aging; Macular Degeneration; Future Planning; Preventive 
Problem-Solving
INTRODUCTION
Age-related Macular Degeneration (AMD) is the leading cause of irreversible and 
predictable blindness among older adults. About 5% of individuals aged 60–64 have early 
stages of the disease1; rates of severe AMD double with each decade after age 60.2 AMD is 
associated with blurring or distortion of central vision, a central blind spot, and loss of 
detail-, contrast-, and color-vision.3 Common consequences are an inability to drive, read, 
watch television, recognize people, and engage in other valued, discretionary activities4, 
especially those outside the home, which are central to well-being.5 Visual impairment often 
leads to a negative future outlook6,7 and 33% of patients meet diagnostic criteria for 
depression.8 Thus, AMD has serious consequences for older adults’ quality of life.8–12 
Furthermore, Medicare beneficiaries with vision loss incur significantly higher costs than 
those with normal vision, and approximately 90% of these costs are non–eye related medical 
costs,13 suggesting a growing public health concern for this vulnerable population.
AMD and Preparation for Future Care
In addition to the potential for negative mental health outcomes, the depression symptoms 
often associated with AMD can lead to difficulty with problem-solving and planning for the 
future7,14 and older adults with AMD have lower rates of preparation for future care than 
their non-vision-impaired peers.15 The progressive and sometimes sudden vision loss that 
occurs with AMD places older adults with the disease at increased risk for requiring care 
and/or change of residence. Because of this risk, preparation for future care activities, such 
as being aware of possible care needs, gathering information and making choices about 
preferred types of care, and sharing care plans with caregivers, become especially important 
in creating a future scenario that meets the individual’s needs and preferences. Consistent 
with theories of active life management,16 and proactive coping,17,18 preparation for future 
care (PFC), such as discussing preferences and options for long-term care with family 
members or health care providers, is an adaptive response that improves the management of 
expected age-related losses for most older adults. Indeed, a study of primary care patients 
showed that those with more concrete planning exhibited fewer depression and anxiety 
symptoms after a two year period than those who did not plan.19 In contrast, lack of future 
care planning may lead to distress during care decisions, poor everyday functioning, and 
stress to caregivers.20,21 Lack of planning for vision loss and age-related health decline may 
increase the risk of inappropriate residential or care arrangements22,23 that are not tailored to 
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the patient’s values and preferences. Unnecessary health consequences, such as falls and 
emergency room visits 24–27 may also be viewed as a consequence of poor planning.
Aims
Because of the negative emotional/mental health effects of Macular Degeneration, several 
interventions with older AMD patients have been developed in the last decade. These focus 
on vision rehabilitation,28 adaptive skills training,29 cognitive restructuring or reframing,30 
disease knowledge, self-efficacy in using assistive devices and maintaining activities,31,32 
problem-solving therapy and behavioral activation to prevent depression.33,34 Although 
these studies show that both group interventions and individual home-based problem-
solving training can significantly improve functioning and mood in patients with AMD, the 
beneficial effects rarely exceed 6 months and some have been tested only up to 4 months. 
We postulate that an AMD intervention with an added focus on future care needs will show 
longer lasting effects on well-being. The aims of this paper are (1) to present a new 
intervention that that includes preparation for future losses due to vision and aging, (2) to 
describe an efficacy trial of this intervention, (3) to present evidence for effective 
randomization in the trial; and (4) to compare this intervention to an enhanced control 
condition with regard to retention rates, compliance, and satisfaction.
METHODS
The Macular Degeneration and Aging Study (MADAS) is a randomized clinical trial of 
older adults with AMD in which Preventive Problem-Solving Intervention (PREPSI) is 
tested against an Enhanced Attention Control condition to examine the effectiveness in 
improving psychological well-being, mood, and preparation for future care. PREPSI 
addresses PFC by teaching basic problem-solving and then applying these principles to 
potential future problems. The intervention has two stages. In stage one all participants 
receive vision education classes to equalize knowledge across groups. In stage two they are 
randomized to the intervention or control conditions, which are delivered in-home.
Ethics Approval
The study was approved by the Institutional Review Board of the University of Rochester 
and is registered with ClinicalTrials.gov (NCT02224963). Recruitment has ended, but 
follow-up is ongoing.
Recruitment of Subjects
Adults aged 60+ who have received a diagnosis of AMD were invited to participate: 631 
contacted us by phone in response to advertisements, or were referred to us, with permission 
for us to call them, by the Association for the Blind and Visually Impaired or area clinicians. 
Of these, 67 were not eligible, 42 could not be reached, and 248 declined participation for 
reasons of timing, general lack of interest, or desire for a medical study. A total of 274 
agreed to participate; 50 were unable to start at the time they were asked, had family or 
health issues, or changed their mind. We consented and completed the baseline interview 
with 224 participants; 207 attended the vision education classes. Subject flow is shown in 
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Figure 1. Recruitment into the trial began in September of 2009 and ended in February of 
2014.
Inclusion/Exclusion Criteria—Inclusion criteria were (1) diagnosis of AMD (2) 60 
years and older; (3) able to communicate in English.
After interview 1, subjects were excluded if they: (1) had significant cognitive impairment at 
baseline (total score on MMSE(Blind) <18 35 (n=5), equivalent to <21 used in other aging 
studies36; (2) resided in a nursing home (assisted living facilities were acceptable) (n=0); (3) 
were acutely suicidal, psychotic (PI and the clinical psychologist/psychiatrist were paged 
immediately, n=0), or if their homes were deemed unsafe for staff (n=2). Patients were also 
excluded if they had a terminal illness preventing completion of the intervention (n=6). Four 
were lost to follow-up after interview 1.
Primary Recruitment Sites and Strategies—Participants were recruited from a 
number of sites: The Association for the Blind and Visually Impaired (ABVI, 30%), the 
University of Rochester’s Flaum Eye Institute (FEI, 9%) and local retinal practices (2%). 
We also used local media (29% of recruited participants), including newspaper 
advertisements, television appearances. Finally we reached 30% of participants through 
presentations at local senior centers, professional societies, and faith-based organizations.
Consent
Potential participants were informed during recruitment and over the phone about the 
purpose, the design, and the duration of the study. The initial phone contact was conducted 
by a staff member, who ensured that the study was adequately explained. All participants 
were consented during their first assessment visit in their home. The study was explained 
again during this visit. Consent was obtained by study staff and a sighted witness.
Study Design, Randomization, and Withdrawal Procedures
The study was a community-based efficacy trial of a psycho-educational intervention to 
promote problem-solving skills for solving both current and future problems. The entire 
program, including assessments, lasted 16 weeks. It had a 2 (treatment condition) by 5 
(assessment times) repeated measures design. Assessments were conducted at baseline 
(Interview 1), after the vision education classes (Interview 2), after the first 4 weeks of 
treatment (Interview 3), at post-treatment (Interview 4), and at 6 months post-trial (Interview 
5). Both treatment and control participants met the consenting research assistant at their first 
assessment visit. Both groups also attended the four Vision Education (VE) classes. 
Following the last VE class, participants were randomly assigned to an 8-week Preventive 
Problem-Solving Training Intervention (PREPSI) or an Enhanced Attention Control (EAC) 
condition (described below).
Participants were randomized using an urn randomization program adjusting for gender, age, 
living alone, wet or dry AMD, recruitment site, and receipt of low-vision services. Group 
assignment was communicated to the participants by the project coordinator and 
randomization was conducted independently of recruitment. Of the 207 who participated in 
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classes, 26 withdrew before Interview 2 and one before randomization. Reasons for 
withdrawal included health (n=2), too busy or no longer interested (n=6), didn’t like the 
questions (n=4), loss to follow-up (n=3), died (n=3), other or reason unkown (n=9).
Data Collection
Data were collected at five measurement points: Baseline (Interview 1), after vision 
education classes (Interview 2), after problem-solving training (Interview 3), after 
preparation for future care training (Interview 4) and after a 6-month follow-up period 
(Interview 5). Demographic data about participants were collected at the first home visit, 1–
2 weeks before the beginning of the intervention. Characteristics of the participants are 
shown in Tables 1a.
Other data collected included detailed assessments of psychological well-being, depression 
and anxiety, attitudes toward the future, preparation for future care, valued activities, life 
satisfaction, and life events. Changes were assessed through repeated measurement at every 
visit, as well as by asking about recent changes in health, vision, well-being, finances, and 
family. Phone assessments of satisfaction with the intervention were conducted after the 
fourth interview. Although we attempted to keep interviewers unaware of group assignment 
of the participants, by visit 4 41% of participants had unblinded their interviewer 
inadvertently (51.4 % of the PREPSI and 30.3% of the control group). However, by the 6-
month follow-up the proportion of participants with unblinded interviewers was 37% in both 
groups.
Retention and Tracking—Measures to increase retention included: (1) ensuring subject 
clarity about the content and commitment of the study; (2) screening out individuals too ill 
to follow through (acute terminal or life-threatening illness) or too cognitively impaired 
(MMSE(Blind)<18); (3) providing transportation to classes at ABVI; (4) conducting the 
problem-solving component of the intervention in the home. The barriers to travel for 
vision-impaired older adults outweighed the potential variability and privacy violations 
encountered in the home.
To aid in longitudinal follow-up and retention, we obtained the name of a relative or friend 
who could be contacted in the case of an unexpected change of address. Some participants 
were referred by their eye doctor and had not yet received a low vision assessment at ABVI. 
A make-up visit at ABVI was scheduled for these participants early in the study, ensuring 
that vision function was assessed subjectively and objectively, and that participants received 
needed vision rehabilitation services, if indicated.
The Preventive Problem-solving Intervention (PREPSI)
The PREPSI consisted of three components: (1) four Vision Education (VE) classes; (2) four 
formal problem-solving training visits (PST); and (3) four preparation for future care 
training visits (PFCT). The Vision Education classes were conducted at the Association for 
the Blind and Visually Impaired-Goodwill (ABVI); with transportation assistance provided. 
ABVI physicians, vision rehabilitation team leaders, and rehabilitation specialists co-
developed the VE groups with the research team and taught the classes. The eight PST/
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PFCT sessions and four assessment visits were conducted in participants’ homes, and 
administered by bachelor’s or master’s level human service professionals who were certified 
in Problem-Solving Therapy and Preparation for Future Care Training. A given PREPSI 
trainer was assigned to the same patient throughout the study.
Vision Education (VE)—This component consisted of four group classes and provided 
general information about the medical aspects of Macular Degeneration, adapting to vision 
loss, as well as social support and emotion management training. The informational content 
of the Vision Education groups resembled the information provided to individual clients of 
the Association for the Blind and Visually Impaired (ABVI). In addition, VE classes created 
a supportive group setting in which to voice concerns and discuss common issues. Group 
support has been recognized as an important aspect of AMD interventions.30 The Vision 
Education classes covered (1) physiological processes of AMD, including how it is 
diagnosed, risk and preventive factors, and current treatments; (2) in-home adaptations that 
allow visually impaired adults to remain independent, for example, the use of assistive 
devices, lenses, and clothing color identification strategies; (3) orientation and mobility 
skills, for example, how to use public transportation, obtain identification canes, and 
paratransit; and (4) social and emotional adaptation to vision loss, including a cognitive-
behavioral emotion management component.
All subjects received a binder to insert notes from the VE groups, a large-print resource 
listing with names of local agencies for older adults, and information about care options, and 
legal and financial issues of caregiving.
Problem-solving Training (PST)—This standardized four-session program for learning 
a systematic approach to solving self-identified problems was taught using a stepwise 
approach to solving a problem of the participant’s choice. The steps include (1) fostering 
positive problem-orientation, or the perspective that having problems is normal and that one 
can cope with them systematically and effectively; (2) defining problems and setting goals; 
(3) generating alternative solutions by brainstorming; (4) deciding on preferred solutions by 
considering pros and cons; (5) implementing solutions or plans for solutions and evaluating 
solution effectiveness.37 Problems were chosen by the subjects -- they were often, but not 
always, about vision-related difficulties. Follow-up sessions focus on evaluating progress on 
the chosen solutions.
Applying PST to Preparation for Future Care—This four session component applied 
the principles and skills learned in the previous problem-solving sessions to potential future 
problems. We introduced the principles of “overcoming avoidance” and “becoming aware of 
future needs and options”, as well as “gathering information,” “decision-making,” and 
“concrete planning,” which are key actions in preparation for future care38 (Figure 2). The 
message was conveyed that anticipating and planning for future difficulties can make 
finding solutions and adapting to vision and health changes easier and result in less distress.
Resource Information Modules—Because previous studies have shown that 
information provided to older AMD patients is often not utilized independently, we devised 
six Resource Information Modules. These 10 minute mini-lectures were accompanied with 
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large-print written information in a binder, which were presented during the PST and PFCT 
sessions, and focused on Transportation, Area Agency of Aging Nutrition Sites, 
Opportunities for Leisure Activities for Seniors, and Senior housing Options, In-home care 
Options, and Medical Decision-Making & Power of Attorney.
Description of the Enhanced Attention Control (EAC) Condition
The EAC was designed to control for non-specific benefits of social contact and information 
provision. It consists of two components: (1) four Vision Education (VE) groups and (2) a 
schedule of home visits and assessments with control subjects that was structurally 
equivalent to the PREPSI, but did not include the problem-solving content. The EAC was 
presented as a credible alternative to the PREPSI: It was framed to both trainers and subjects 
as a “Life and Health Review Intervention.” Trainers were instructed to engage the 
participant in a structured life review, discussing events from each life stage, based on 
Erikson’s theory (e.g., childhood, adolescence, young adulthood). Our Life Review 
procedures manual was adapted from Matteson.39,40 Additionally, EAC trainers interviewed 
participants about current health concerns and, if appropriate, provided health information 
(e.g., basic nutrition advice, brochures on osteoporosis, etc.). EAC participants received the 
same Resource Information Modules and mini-lectures as the treatment group.
Experimental Blinding
Several strategies maximized experimental blinding. Patient blinding occurred, first, by 
describing the study in the consent as a comparison of two interventions to improve well-
being of AMD patients. The stated rationale was that the Life Review Intervention would 
improve mood as well as access to information. Structural equivalence of the two 
conditions, provision of health promotion and resource information, audio-taped sessions, 
and careful record keeping in the EAC contributed to patients’ perceptions of its legitimacy. 
We administered a treatment expectations questionnaire to detect possible between-group 
difference in patients’ expectations about treatment progress. Although it was not feasible to 
achieve trainer-blinding to study hypotheses, we attempted to enhance EAC trainers’ 
perception of the legitimacy of the Life Review Intervention by structural equivalence of the 
two conditions, provision of regular social contact, sharing medical and resource 
information, and the stated rationale enhanced their motivation and helped obscure the 
experimental assignment for patients.39 EAC Trainers were informed that they were 
applying a modification of a previously tested depression intervention. EAC trainers audio-
taped the session and tracked participant involvement, topics discussed, and quality of 
rapport with the participant.
Assessor blinding was achieved by separating the tasks of trainers and assessors, who were 
instructed not to discuss case details in project meetings. The study coordinator was not 
blinded to group assignment. She informed the patients of the identity of their “trainer” and 
passed the patient’s contact information to the assessors and trainers. All communications 
between assessors and trainers about participants were relayed through the coordinator. The 
assessor conducted the baseline and follow-up interviews and had regular phone contacts 
with the participants between assessment periods. Patients were reminded repeatedly to 
avoid disclosing information to assessors that could reveal their treatment assignment. 
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Reminders were made during informed consent, during between-assessment phone calls, 
and prior to assessment interviews. All instances of broken blind, due to the participants 
sharing experience or names of trainers, were recorded.
Staff Training and Intervention Fidelity
Staff received ten hours of training in protocol, recruitment strategies, and data entry 
including a General Procedure Manual. All Staff received five hours of training in sources of 
vision loss, cultural sensitivity to vision loss, and introduction to visual aids by expert 
rehabilitation specialists at ABVI. In addition to 5 hours of instruction on medical and 
psychological issues in aging, aging resources, and effective communication with older 
adults and 3 hours per year of cultural sensitivity training were provided. Staff members met 
weekly with the PI and Study Coordinator to ensure uniformity of recruitment, protocol 
implementation, data collection and entry.
PREPSI Trainers—The three PREPSI trainers received at least 50 hours of training. They 
participated in a full-day workshop conducted by a PST training specialist, co-author MTH. 
The workshop included a didactic presentation, viewing and discussing training videotapes, 
reviewing the treatment manual, role-playing by participants, and discussion. Each PREPSI 
trainer also completed 5 supervised training cases of 4 consecutive sessions over 4 weeks. 
Audio files of the first, second, and fourth PREPSI sessions were reviewed and rated by 
MTH using the PST Adherence and Competence Scale (PST-PAC).41 MTH provided 
detailed feedback to the trainers in 30-minute phone supervision meetings. Trainers were 
required to meet satisfactory levels of competence (defined as mean scores ≥ to 3, in a range 
of 0–5, on the PST-PAC for their last 2 training cases) before being certified to work with 
the AMD patients. Special attention was focused on adherence to principles and activities 
outlined in the PREPSI manual, as well as the ability to interact with older adults who have 
vision impairments. In addition, the PI or project coordinator conducted a training on the 
PFC modules and the Resource Information Modules. Trainers discussed their progress in 
supervision with the PI or the study coordinator in weekly ½ hour sessions. One trainer was 
replaced during the third year of the study.
EAC Trainers—Over the course of the study, a total of ten control group trainers were 
instructed to do life review. They attended 8 hours of training introducing them to Erikson’s 
life stages 42, teaching open-ended questioning techniques, and empathetic listening, and 
discussing the Resource Information Modules. They completed two supervised practice 
cases of 8 1-hr sessions each. EAC trainers delivering the Life Review received the same 
sensitivity training protocol as the PREPSI trainers.
Several measures were taken to ensure treatment fidelity:
Qualified Trainers—Although the PST approach does not require extensive psychological 
training or background knowledge and can be taught to a variety of health 
professionals41,43,44, trainers were selected for educational background and skills that 
promise ability to carry out the training protocol.
Sörensen et al. Page 8
Contemp Clin Trials. Author manuscript; available in PMC 2016 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Manualization—The intervention manual provides clear guidelines for introducing and 
describing characteristics of the treatment process, and outlining sequencing techniques and 
what steps to take in effective implementation.45 Manuals diminish variability in treatment 
adherence.46 The Life Review training was also manualized in order to enhance consistency 
among the EAC trainers.
High Acceptability of Treatment may facilitate therapist’s ability to follow the intended 
protocol.45 Because the PREPSI is brief, easily understood, and framed as an educational 
program (as opposed to psychotherapy) -- thus avoiding a common barrier to treatment – it 
is perhaps more ‘acceptable’ to older adults. Adherence rates in past studies were relatively 
high and dropout rates relatively low.47 We reasoned that this would motivate PREPSI 
trainers to be faithful to the protocol.
Behavior-based Adherence Ratings—Because of social desirability issues with self-
report45, treatment fidelity was assessed using the PST-PAC checklist, revised to reflect the 
PREPSI modifications, to rate randomly selected audio-taped PREPSI sessions. The 
checklist was developed by MTH for assessing treatment fidelity during PST training on the 
following dimensions: Defining the Problem; Establishing a Realistic Goal; Brainstorming 
Solutions; Implementing Decision Making Guidelines; Implementation of Solutions; 
Processing Tasks; Communication, Personal Effectiveness, and a global rating. MTH rated 
approximately 10% of the accumulated recorded sessions at 6-month intervals during the 
intervention period using the PST-PAC checklist. Protocol deviations were discussed in 
supervision. These procedures prevented treatment drift. Average global ratings for the three 
primary PREPSI trainers ranged from 4.2 to 4.9 out of 5, with an increasing trend with 
practice. For processing tasks, the lowest-scoring the dimension, the average rating was 
across all trainers was 3.96 out of 5.
Supervision of PREPSI Trainers and Treatment Drift Monitoring—All trainers 
participated in group supervision sessions led by the PI and project coordinator. In these bi-
weekly meetings they discussed issues and problems that arose during training and 
reinforced trainer adherence to their specific protocols. Discussions were used to explore 
alternate approaches to difficult patients or situations, since these techniques have been 
shown to increase fidelity.45 A clinical psychologist joined the PREPSI trainer meeting 
monthly to discuss emergent clinical issues to be available for consultation as needed.
Measurement Strategy
Participants were assessed in weeks 1, 6, 11, and 16, and 6 months post-intervention. At 
each visit we assessed changes in the participant’s vision functioning, recent use of ABVI or 
other vision-related services, current diagnosis, treatment, and medication/vitamin use. In 
assessment 2 we also asked about satisfaction with VE groups, and in assessment 4 we 
addressed satisfaction with the PST and PFCT components. At the 6-month follow-up we 
updated demographics, assessed outcome measures and potential interference variables (e.g., 
changes in social network and health, life events and changes in marital status, health, 
family relationships, finances, housing). We also asked about the participant’s visual acuity, 
requested updates from their retina specialist, and about use of low-vision services.
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All participant measurements were carried out in interview format. Large print answer cards 
were used for responding to Likert style items. If the participant was unable to read these, 
the interviewer repeated the answer options as many times as necessary until the participant 
was able to use them, or the interviewer applied stepwise questioning, e.g., “do you agree or 
disagree; do you disagree strongly, moderately, or slightly?”
Interviews lasted 1–3 hours, depending on the participants’ ability to comprehend question 
and answer formats, and on their talkativeness. Assessors were instructed to end any 
interview exceeding 2.5 hours and reschedule to continue at another time. They were also 
trained to recognize fatigue and respond with a break in the interview or by rescheduling.
Instruments—Variables were grouped into the following categories: Emotional Well-
being outcomes; Future Outlook and Planning, Functional outcomes. Three outcomes were 
tested for successful randomization. The first was the Psychological Well-Being scale 
(PWB),48 a 42-item multidimensional measure assessing 6 dimensions of PWB: Autonomy, 
Environmental Mastery, Personal Growth, Positive Relations With Others, Purpose In Life, 
and Self-Acceptance. It is a Likert-scored self-report measure, with anchors of “1-disagree 
strongly” and “6-agree strongly.”49–52. (2) The second was the Preparation for Future Care 
Measure (PFCM),53 which has been validated with community-dwelling older adults, and 
has acceptable internal consistency and retest reliability. It consists of 29 items in five 
subscales that assess specific behaviors representative of each of five processes observed in 
PFC: Awareness of care needs: “Talking to other people has made me think about whether I 
might need help or care in the future.” Gathering Information: “I have gathered information 
about options for care by talking to friends or family.” Deciding on Preferences: “If I ever 
need help or care, I can choose between several options that I have considered in some 
depth.” Making Concrete Plans:” I have explained to someone close to me what my care 
preferences are.” Avoidance:” I avoid negative topics like future dependence.” The third 
measure to test for successful randomization was the total score of the Vision Function 
Questionnaire, a 25-item National Eye Institute-approved Vision Functioning Assessment 
(NEI-VFQ-25). 5455
Treatment Compliance and Enactment of Skills—Compliance and resistance were 
documented by the PREPSI trainer after each session. Trainers record attendance, reluctance 
to engage in problem-identification or solution generation, content of the problem, 
completion of the problem-solving process, relevance of the action plan, compliance with 
homework, success of homework, patient’s understanding and application of PST principles, 
and extent of problem resolution. In the PFCT section, they also documented whether the 
problem chosen was future-oriented. Because EAC trainers could not document enactment 
of skills, participation in all EAC sessions before the visit 4 assessment was used as a 
measure of compliance.
Data analysis
In order to demonstrate adequate randomization, we compared PREPSI and EAC, as well as 
non-randomized subjects with regard to baseline scores on the demographic variables. We 
also checked randomization with regard to the three groups of well-being outcomes that will 
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be the focus of future efficacy analysis: Six psychological well-being (PWB) subscales, five 
preparation for future care (PFC) subscales, and a measure of vision functioning (NEI-
VFQ). We then compared the groups on three process outcomes: (1) Retention rates, (2) 
compliance (number of sessions attended), and (3) satisfaction ratings. We used Chi-square 
tests for categorical variables and analysis of variance for ordinal and continuous variables. 
For data tables with expected values <5 we used Fisher’s exact test. Although the primary 
hypothesis of this efficacy trial are that the trajectories of PFC and PWB will be 
significantly different for treatment and control group at visits 4 and 5, this hypothesis will 
not be tested until the trial is complete, thus the results are not reported here.
Results
Tables 1a and 1b show no differences between treatment, control, and non-randomized 
subjects on any demographic variables and urn randomization covariates.
At baseline, treatment and control groups did not differ in Psychological Well-being, 
Preparation for Future care, or total vision functioning score (the outcome variables chosen 
for the efficacy trial, Table 2). Treatment and control also did not differ from the non-
randomized group in these variables.
Retention rates between randomization to post-intervention (visit 4) for the treatment group 
(90%) and control group (88%) were comparable in a chi-square test (χ2(1)=.26, p=.16), as 
were the rates between randomization and 6-month follow-up (visit 5) (χ2(1)=.61, p=.33; 
treatment group= 62%; control group=68%). The number of sessions attended (7.1 vs. 6.7) 
were also not significantly different between the two treatment groups.
A random subset of participants (n=73, 53% PREPSI, 47% control) were surveyed about 
their satisfaction with the program. We used a modified version of the Client Satisfaction 
Survey.56 We created a satisfaction index (α=.86) from eight items and compared PREPSI 
and Control group participants with regard to the satisfaction index. In a t-test, the two 
treatment groups did not differ in satisfaction. Twenty-two percent had an average score of 4 
(e.g., “very satisfied”), 67% ranged from 3–3.9 (e.g., “mostly satisfied), and the rest reported 
an average score of 2.5–2.9 (“indifferent or mildly satisfied”); no one had an average score 
below 2 (e.g., “not satisfied”). The majority of participants (87%) felt that the trainer 
listened to them very closely during either condition. None felt that trainers were poor 
listeners. Also, 98% felt that their rights as an individual were respected.
Among the PREPSI participants, the question “How useful did you find the in-home training 
sessions?” was answered by 43% with “very useful,” 28% “quite useful” and 28% 
“somewhat useful.” Nine percent found the in-home training less useful than the classes, 
13% found them more useful, and 76% found them equally useful. One quarter of PREPSI 
respondents found the future planning training more useful than the standard problem-
solving training sessions; two thirds found the two equally useful; only 3 % found the future 
planning training less useful.
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DISCUSSION
We offer a detailed research protocol for the Macular Degeneration and Aging Study. This is 
the first randomized controlled trial to address both Psychological Well-being and 
Preparation for Future Care in a older population with vision-threatening eye disease. Our 
analyses suggest that subjects could be successfully randomized, that they were equally 
satisfied regardless of which group they were randomized to, and that retention rates and 
compliance were comparable for the treatment versus the control groups. Furthermore, 
although unblinding was more likely for the treatment than the control group, at follow-up it 
was equally likely for both groups.
Several considerations were important in developing this protocol. First, we considered 
using enhanced Treatment as Usual as control – that is, providing only Vision Education and 
resources instead of social attention visits – but results from the pilot study suggested that 
the attention that participants receive from weekly visits may enhance their well-being, even 
if it does not enhance their PFC cognitions and behaviors. The chosen design placed fewer 
limitations on study conclusions by strengthening the control condition, but increased the 
risk of non-significant findings.
Participants were urn randomized into the two study groups in order to balance potential 
confounders. However, unmeasured variables may still influence the results. Also, we found 
that people with longer time since diagnosis were more likely to drop out before 
randomization. We will therefore include these potential confounders in more detailed 
analyses. Since younger patients have had less time to adjust to AMD, we will control for 
age; because men were less likely to seek out social support, and because living alone 
increases the risk of having unmet needs, these variables will be included in the analyses and 
we will assess their potential as effect modifiers (moderators).
Given the public health relevance of late life vision loss due to macular degeneration, the 
results of this study will have implications for vision care in community settings and for 
public health policies for reimbursement of psychosocial treatments in vision loss care.
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Figure 2. 
Application of PST Steps to PFC Problems
Sörensen et al. Page 17
Contemp Clin Trials. Author manuscript; available in PMC 2016 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Sörensen et al. Page 18
Ta
bl
e 
1a
Co
m
pa
ris
on
 o
f P
ar
tic
ip
an
t C
ha
ra
ct
er
ist
ic
s a
m
on
g 
Pa
rti
ci
pa
nt
s i
n 
Tr
ea
tm
en
t, 
Co
nt
ro
l, 
an
d 
N
ot
-R
an
do
m
iz
ed
 g
ro
up
s (
ord
ina
l o
r c
on
tin
uo
us
 va
ria
ble
s)
V
ar
ia
bl
es
PR
EP
SI
M
ea
n 
(S
D)
 (N
=9
0)
EA
C
M
ea
n 
(S
D)
 (N
=9
0)
N
ot
 ra
nd
om
iz
ed
M
ea
n 
(S
D)
 (N
=3
3)
F-
st
at
ist
ic
 (p
-va
lue
) o
f 3
-w
ay
 
di
ffe
re
nc
e
To
ta
l
M
ea
n 
(S
D)
 (N
=2
13
)
A
ge
 (Y
ea
rs)
80
.8
1 
(7.
38
)
80
.2
7 
(7.
70
)
70
.8
2 
(10
.77
)
.
78
7 
(p=
.46
)
80
.2
6 
(8.
09
)
Ed
uc
at
io
n 
(Y
ea
rs)
14
.2
7 
(2.
61
)
14
.2
9 
(2.
48
)
15
.1
2 
(3.
39
)
1.
37
 (p
=.2
6)
14
.1
4 
(2.
70
)
1
le
ss
 th
an
 $1
0,0
00
 pe
r y
ea
r
2
$1
0,0
00
 to
 $1
9,9
99
 pe
r y
ea
r
3
$2
0,0
00
 to
 $2
9,9
99
 pe
r y
ea
r
4
$3
0,0
00
 to
 $3
9,9
99
 pe
r y
ea
r
5
$4
0,0
00
 to
 $4
9,9
99
 pe
r y
ea
r
6
$5
0,0
00
 to
 $5
9,9
99
 pe
r y
ea
r
7
$6
0,0
00
 to
 $6
9,9
99
 pe
r y
ea
r
8
$7
0,0
00
 to
 $7
9,9
99
 pe
r y
ea
r
9
$8
0,0
00
 to
 $8
9,9
99
 pe
r y
ea
r
10
$9
0,0
00
 to
 $9
9,9
99
 pe
r y
ea
r
11
m
o
re
 th
an
 $1
00
,00
0 p
er 
ye
ar
4.
68
 (2
.84
)
5.
41
 (3
.14
)
5.
59
 (3
.60
)
1.
65
0 
(p=
.20
)
5.
12
 (3
.09
)
Fi
na
nc
ia
l A
de
qu
ac
y 
Co
m
po
sit
e 
(1=
 no
t a
t a
ll; 
5=
mu
ch
 m
ore
 th
an
 ad
eq
ua
te)
2.
56
 (.5
3)
2.
58
 (.4
8)
2.
61
 (.5
7)
.
14
 (p
=.8
7)
2.
57
 (.5
1)
Contemp Clin Trials. Author manuscript; available in PMC 2016 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Sörensen et al. Page 19
Ta
bl
e 
1b
Co
m
pa
ris
on
 o
f P
ar
tic
ip
an
t C
ha
ra
ct
er
ist
ic
s a
m
on
g 
Pa
rti
ci
pa
nt
s i
n 
Tr
ea
tm
en
t, 
Co
nt
ro
l, 
an
d 
N
ot
-R
an
do
m
iz
ed
 G
ro
up
s (
ca
teg
ori
ca
l v
ari
ab
les
)
PR
EP
SI
N
 (%
) (
N=
90
)
EA
C
N
 (%
) (
N=
90
)
N
ot
 ra
nd
om
iz
ed
N
 (%
) (
N=
27
)
χ2
-
st
at
ist
ic
 (p
-va
lue
)a  
o
f 3
-w
ay
 d
iff
er
en
ce
To
ta
l
N
 (%
) (
N=
21
3)
G
en
de
r
 
M
al
e
31
 (3
4.4
%)
33
 (3
6.7
%)
14
 (4
2.4
%)
.
66
3(p
=.7
2)
D
f=
2
78
 (3
6.6
%)
 
Fe
m
al
e
59
 (6
5.6
%)
57
 (6
3.3
%)
19
 (5
7.6
%)
13
5 
(63
.4%
)
R
ac
ea
 
W
hi
te
85
 (9
4.4
%)
87
 (9
8.9
%)
33
 (1
00
%)
3.
63
 (p
=.4
3)
D
f=
4
20
5 
(97
.2%
)
 
B
la
ck
3 
(3.
3%
)
0
0
3 
(1.
4%
)
 
O
th
er
2 
(2.
2%
)
1 
(1.
1%
)
0
3 
(1.
4%
)
Et
hn
ic
ity
 a
 
La
tin
o
1 
(1.
1%
)
1 
(1.
1%
)
0
.
59
6 
(p=
.99
) (
La
tin
o v
ers
us
 ot
he
r)
D
f=
2
2(.
9%
)
 
N
ot
 L
at
in
o
88
 (9
8.9
%)
88
 (9
8.9
%)
33
 (1
00
%)
20
9 
(99
.1%
)
 
En
gl
ish
/S
co
tti
sh
-A
m
er
ic
an
41
 (4
5.6
%)
30
 (3
3.3
%)
14
 (4
2.4
%)
85
 (3
9.9
%)
 
Ir
ish
-A
m
er
ic
an
25
 (2
7.8
%)
24
 (2
6.7
%)
11
 (3
3.3
%)
60
 (2
8.2
%)
 
G
er
m
an
-A
m
er
ic
an
36
(40
%)
38
 (4
2.2
%)
13
 (3
9.4
%)
87
 (4
0.8
%)
 
Ita
lia
n-
A
m
er
ic
an
7 
(7.
8%
)
8 
(8.
9%
)
2 
(6.
1%
)
17
 (8
%)
 
R
us
sia
n-
A
m
er
ic
an
0
2 
(2.
2%
)
0
2 
(.9
%)
 
Je
w
ish
-A
m
er
ic
an
5 
(5.
6%
)
0
0
5 
(2.
3%
)
(in
clu
de
s i
nd
ivi
du
als
 w
ho
 in
dic
ate
d m
ult
ipl
e E
thn
ici
tie
s)
Ty
pe
 o
f A
M
D
a
 
W
et
25
 (3
2.5
%)
23
 (3
2.4
%)
11
 (3
9.3
%)
3.
83
 (p
=.7
6)
df
=6
59
 (3
3.5
%)
 
D
ry
39
 (5
0.6
%)
34
 (4
7.9
%)
15
 (5
3.6
%)
88
 (5
0%
)
 
B
ot
h
13
 (1
6.9
%)
13
 (1
8.3
%)
2 
(7.
1%
)
28
 (1
5.9
%)
 
O
th
er
 T
yp
e
0
1 
(1.
4%
)
0
0
Li
vi
ng
 A
lo
ne
47
 (5
2.2
%)
43
 (4
7.8
%)
18
 (5
4.5
%)
.
58
6 
(p=
.75
)
D
f=
2
10
8 
(50
.9%
)
M
ar
ita
l S
ta
tu
s
M
ar
rie
d 
(li
vin
g w
ith
 sp
ou
se 
or 
pa
rtn
er)
36
 (4
0%
)
33
 (3
6.7
%)
13
 (3
9.4
%)
.
22
4 
(p=
.89
) (
ma
rri
ed
 ve
rsu
s a
ll o
the
rs)
82
 (3
8.5
%)
82
 (3
8.5
%)
Contemp Clin Trials. Author manuscript; available in PMC 2016 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Sörensen et al. Page 20
PR
EP
SI
N
 (%
) (
N=
90
)
EA
C
N
 (%
) (
N=
90
)
N
ot
 ra
nd
om
iz
ed
N
 (%
) (
N=
27
)
χ2
-
st
at
ist
ic
 (p
-va
lue
)a  
o
f 3
-w
ay
 d
iff
er
en
ce
To
ta
l
N
 (%
) (
N=
21
3)
D
f=
2
N
ot
 M
ar
rie
d
 
W
id
ow
ed
42
 (4
6.7
%)
40
 (4
4.4
%)
12
 (3
6.4
%)
94
 (4
4.1
%)
 
D
iv
or
ce
d
5 
(5.
6%
)
9 
(10
.0%
)
5(1
5.2
%)
19
 (8
.9%
)
 
Si
ng
le
5 
(5.
6%
)
6 
(6.
7%
)
2 
(6.
1.%
)
13
 (6
.1%
)
 
O
th
er
2 
(2.
2%
)
2 
(2.
2%
)
1 
(3.
0%
)
5 
(2.
3%
)
Le
ga
lly
 B
lin
d
32
 (3
6.8
%)
25
 (3
0.1
%)
9 
(32
.1%
)
.
86
9 
(p=
.65
)
D
f=
2
66
 (3
3.3
%)
R
ec
ei
ve
d 
lo
w
-v
isi
on
 se
rv
ic
es
49
 (5
4.4
%)
49
 (5
4.4
%)
13
 (4
0.6
%)
2.
08
 (p
=.3
5 D
f=
2)
11
1 
(52
.4%
)
Le
ng
th
 o
f D
ia
gn
os
is
 
2 
ye
ar
s o
r l
es
s
19
 (2
3.2
%)
21
 (2
6.6
%)
10
 (3
4.5
%)
7.
87
 (p
=.0
9)
df
=4
50
 (2
6.3
%)
 
3–
9 
ye
ar
s
38
 (4
6.3
%)
33
 (4
1.8
%)
5 
(17
.2%
)
76
 (4
0.0
%)
 
10
 y
ea
rs
 o
r m
or
e
25
 (3
0.5
%)
25
 (3
1.6
%)
14
 (4
8.3
%)
64
 (3
3.7
%)
N
ot
e.
 V
ar
ia
tio
n 
in
 to
ta
ls 
is 
du
e 
to
 m
iss
in
g 
va
lu
es
.
a
Fi
sh
er
’s
 E
xa
ct
 T
es
t
Contemp Clin Trials. Author manuscript; available in PMC 2016 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Sörensen et al. Page 21
Ta
bl
e 
2
Co
m
pa
ris
on
 o
f P
ar
tic
ip
an
ts 
in
 T
re
at
m
en
t, 
Co
nt
ro
l, 
an
d 
N
ot
-R
an
do
m
iz
ed
 G
ro
up
s w
ith
 R
eg
ar
d 
to
 T
ria
l O
ut
co
m
e 
V
ar
ia
bl
es
V
ar
ia
bl
es
PR
EP
SI
M
ea
n 
(S
D)
 (N
=9
0)
EA
C
M
ea
n 
(S
D)
 (N
=9
0)
N
ot
 r
an
do
m
iz
ed
M
ea
n 
(S
D)
 (N
=3
3)
F-
st
at
ist
ic
p-
va
lu
e
PW
B 
- A
ut
on
om
y
4.
72
 (.8
2)
5.
85
 (.8
2)
4.
78
 (.7
5)
.
56
1
.
57
1
PW
B 
– 
En
vi
ro
nm
en
ta
l M
as
te
ry
4.
76
 (.8
8)
4.
83
 (.7
6)
4.
69
 (.7
7)
.
39
9
.
67
1
PW
B 
– 
Pe
rs
on
al
 G
ro
w
th
4.
71
 (.8
4)
4.
80
 (.8
2)
4.
69
 (.9
5)
.
30
7
.
73
6
PW
B 
– 
Po
sit
iv
e 
Re
la
tio
ns
hi
ps
5.
00
 (.8
2)
5.
01
 (.6
9)
4.
95
 (.9
2)
.
21
9
.
80
3
PW
B 
– 
Pu
rp
os
e 
in
 L
ife
4.
46
 (.9
9)
4.
34
 (.8
7)
4.
18
 (.9
3)
1.
07
2
.
34
4
PW
B 
– 
Se
lf-
A
cc
ep
ta
nc
e
4.
63
 (.8
9)
4.
59
 (.9
7)
4.
51
 (1
.08
7)
.
15
5
.
85
6
PF
C-
A
w
ar
en
es
s
3.
33
 (.9
2)
3.
39
 (.8
2)
3.
02
 (1
.00
)
1.
85
9
.
15
9
PF
C 
– 
G
at
he
rin
g 
In
fo
rm
at
io
n
2.
93
 (.9
5)
2.
99
 (.9
4)
2.
99
 (1
.01
)
.
13
8
.
87
1
PF
C 
– 
D
ec
isi
on
-M
ak
in
g
3.
09
 (.9
8)
3.
07
 (.9
3)
3.
25
 (1
.02
)
.
39
9
.
67
2
PF
C 
– 
Co
nc
re
te
 P
la
nn
in
g
3.
21
 (1
.05
)
3.
31
 (.9
7)
3.
17
 (.8
9)
.
33
3
.
71
7
PF
C 
– 
A
vo
id
an
ce
3.
05
 (.9
7)
2.
80
 (.9
7)
3.
09
 (.9
7)
1.
75
8
.
17
5
N
EI
-V
FQ
 T
ota
l
61
.3
9 
(17
.99
62
.2
6 
(17
.96
)
61
.6
2 
(23
.19
)
.
05
.
95
1
N
ot
e.
 A
ll 
m
ea
n 
va
lu
es
 e
xc
ep
t N
EI
-V
FQ
 w
ere
 m
ea
ns
 ac
ros
s a
ll s
ca
le 
ite
ms
 ra
the
r t
ha
n s
um
ma
ry 
sco
res
. P
W
B=
Ps
yc
ho
log
ica
l W
ell
-B
ein
g; 
PF
C=
Pr
ep
ara
tio
n f
or 
Fu
tur
e C
are
; N
EI
-V
FQ
= N
ati
on
al 
Ey
e 
In
st
itu
te
 V
isi
on
 F
un
ct
io
ni
ng
 Q
ue
sti
on
na
ire
.
Contemp Clin Trials. Author manuscript; available in PMC 2016 May 01.
